4-butyrolactone has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, J; Du, J; Liu, Z; Lu, Q; Zheng, R; Zhu, P | 1 |
1 other study(ies) available for 4-butyrolactone and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Hinokinin alleviates high fat diet/streptozotocin-induced cardiac injury in mice through modulation in oxidative stress, inflammation and apoptosis.
Topics: 4-Butyrolactone; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzodioxoles; Blood Glucose; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diet, High-Fat; Dyslipidemias; Hyperglycemia; Lignans; Mice; Oxidative Stress; Signal Transduction; Streptozocin | 2021 |